Sugi Predict

Sugi Predict / Compounds / SCHEMBL7697461

SCHEMBL7697461

SCHEMBL7697461

CC1CC(O)CCCCCCCCCCC(O)C1

nearest known ligand 0.50

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 1/20 0.50
▸ CA1 P00915 1/20 0.39
▸ CA2 P00918 1/20 0.39
▸ CA4 P22748 1/20 0.39
▸ LMNA P02545 1/20 0.36
▸ CYP2C9 P11712 1/20 0.36
▸ GAA P10253 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ EPHX1 P07099 1/20 0.33
▸ TRPA1 O75762 2/20 0.31
▸ TRPM8 Q7Z2W7 2/20 0.31
▸ SHBG P04278 1/20 0.31
▸ ACHE P22303 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21554523 0.92 TSHR (0.43) TSHRCA1CA2CA4LMNA
SCHEMBL2195341 0.92 TSHR (0.47) TSHRCA1CA2CA4LMNA
SCHEMBL2197377 0.92 TSHR (0.47) TSHRCA1CA2CA4LMNA
SCHEMBL4841935 0.92 TSHR (0.47) TSHRCA1CA2CA4LMNA
SCHEMBL6055429 0.92 TSHR (0.47) TSHRCA1CA2CA4LMNA
SCHEMBL17393428 0.92 TSHR (0.47) TSHRCA1CA2CA4LMNA
SCHEMBL2196681 0.92 TSHR (0.47) TSHRCA1CA2CA4LMNA
SCHEMBL6055449 0.92 TSHR (0.47) TSHRCA1CA2CA4LMNA
SCHEMBL17393310 0.92 TSHR (0.47) TSHRCA1CA2CA4LMNA
SCHEMBL2197346 0.92 TSHR (0.47) TSHRCA1CA2CA4LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108290901-B Process for producing compound having 16-oxabicyclo [10.3.1] pentadecene skeleton and product produced thereafter 巴斯夫欧洲公司 2021-10-08 — — CN claimed
CN-107001214-B Process for producing cyclic diketone compound 花王株式会社 2021-03-23 — — CN claimed
EP-3380477-B1 METHOD FOR THE PREPARATION OF COMPOUNDS WITH 16-OXABICYCLO [10.3.1] PENTADECEN SCAFFOLD AND THEIR SECONDARY PRODUCTS BASF SE (DE) 2021-01-06 — — EP claimed
US-10259822-B2 Method for the preparation of compounds having a 16-oxabicyclo[10.3.1]pentadecene scaffold and the subsequent products thereof BASF SE (DE) 2019-04-16 — — US claimed
US-20180346478-A1 Method for the preparation of compounds having a 16-oxabicyclo[10.3.1]pentadecene scaffold and the subsequent products thereof BASF SE (DE) 2018-12-06 — — US claimed
EP-3380477-A1 METHOD FOR THE PREPARATION OF COMPOUNDS HAVING A 16-OXABICYCLO[10.3.1]PENTADECENE SCAFFOLD AND THE SUBSEQUENT PRODUCTS THEREOF BASF SE (DE) 2018-10-03 — — EP claimed
US-10087129-B2 Method for producing cyclic diketone compound KAO CORPORATION (JP) 2018-10-02 — — US claimed
US-20170362153-A1 METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND KAO CORPORATION (JP) 2017-12-21 — — US claimed
WO-2017089327-A1 METHOD FOR THE PREPARATION OF COMPOUNDS HAVING A 16-OXABICYCLO[10.3.1]PENTADECENE SCAFFOLD AND THE SUBSEQUENT PRODUCTS THEREOF BASF SE (DE) 2017-06-01 — — WO claimed
EP-3170828-A1 METHOD FOR THE PREPARATION OF COMPOUNDS WITH 16-OXABICYCLO [10.3.1] PENTADECEN SCAFFOLD AND THEIR SECONDARY PRODUCTS BASF SE (DE) 2017-05-24 — — EP claimed
EP-3911656-B1 SYNTHESIS OF 14-METHYL-16-OXABICYCLO[10.3.1]HEXADEC-12-ENE INT FLAVORS & FRAGRANCES INC (US) 2025-09-17 — — EP disclosed
WO-2025168763-A1 ENZYMATIC METHOD FOR THE PRODUCTION OF ENRICHED MUSK FRAGRANCE INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 2025-08-14 — — WO disclosed
US-20250214920-A1 METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND KAO CORPORATION (JP) 2025-07-03 — — US disclosed
US-20250214921-A1 METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND KAO CORPORATION (JP) 2025-07-03 — — US disclosed
CN-113302195-B Synthesis of 14-methyl-16-oxabicyclo [10.3.1] hexadec-12-ene 国际香料和香精公司 2025-05-13 — — CN disclosed
WO-2017050713-A1 PROCESS FOR PREPARING 3-METHYLCYCLOPENTADECANE-1,5-DIOL BASF SE (DE) 2017-03-30 — — WO disclosed
WO-2017050713-A1 PROCESS FOR PREPARING 3-METHYLCYCLOPENTADECANE-1,5-DIOL BASF SE (DE) 2017-03-30 — — WO disclosed
JP-2002335991-A NEW CYCLOPENTADECANE DERIVATIVE AND METHOD FOR PRODUCING THE SAME TOYOTAMA KORYO KK 2002-11-26 — — JP disclosed
US-4480107-A Pyranic derivatives useful as intermediates in making muscone FIRMENICH SA (CH) 1984-10-30 — — US disclosed
US-4335262-A Process for the preparation of muscone FIRMENICH SA (CH) 1982-06-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250214920-A1 METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND CYP4F2, DUOX1, BCKDK TSHR 3196/4885CA1 1048/4885CA2 2198/4885
US-10087129-B2 Method for producing cyclic diketone compound AOC2, AOX1, HSD17B12 TSHR 3025/4885CA1 436/4885CA2 1434/4885
US-20180346478-A1 Method for the preparation of compounds having a 16-oxabicyclo[10.3.1]pentadecene scaffold and the subsequent products thereof CYP51A1, HSD17B13, HSD17B7 TSHR 4697/4885CA1 4038/4885CA2 4874/4885
US-20250214921-A1 METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND HSD17B7, HSD17B12, BCKDK TSHR 4605/4885CA1 2942/4885CA2 3272/4885
US-20170362153-A1 METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND AOC2, AOX1, HSD17B12 TSHR 3025/4885CA1 436/4885CA2 1434/4885
US-10259822-B2 Method for the preparation of compounds having a 16-oxabicyclo[10.3.1]pentadecene scaffold and the subsequent products thereof CYP51A1, HSD17B13, HSD17B7 TSHR 4697/4885CA1 4038/4885CA2 4874/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.